So your company’s CEO has coronavirus. Does the world have to know?
By 
Aaron Nicodemus2020-03-25T15:11:00
As infections stemming from the coronavirus pandemic continue to mount around the world, publicly traded companies face questions about when and where to disclose that their CEO or other key executives have contracted the virus.
Related articles
-
ArticleAdvaMed issues pandemic compliance guidance for med-tech
The Advanced Medical Technology Association has released new compliance guidance for medical-technology companies to guide them in mitigating compliance and corruption risks as they help healthcare providers fight coronavirus.
-
Article
SEC’s Clayton stresses importance of coronavirus disclosures
With the close of the first quarter and earnings releases and investor calls around the corner, senior leadership at the SEC is pushing for full disclosure transparency regarding impact of the coronavirus pandemic.
-
Article
SEC provides new coronavirus disclosure guidance
The SEC’s Division of Corporation Finance published guidance to provide clarity regarding its view on disclosure and other securities law obligations during the escalating coronavirus pandemic.
More from Regulatory Policy
-
ArticleFinCEN delays AML rules for realtors and investment advisors until 2028
The Treasury Department’s Financial Crimes Enforcement Network is delaying an upcoming requirement that investment advisors and realtors begin screening clients for money laundering and other illegal activity.
-
News BriefSEC’s Crypto Task Force hits the road with nationwide roundtables
The Securities and Exchange Commission is taking its pro-crypto messaging on the road, planning a series of events for its Crypto Task Force that will be held across the U.S. starting on Aug. 4.
-
Basic PageDOJ warns against using proxies for DEI in federally funded programs
The DOJ is warning that simply scrubbing DEI-related words from policy documents or training materials—and replacing them with thinly veiled proxies—will not protect federally funded organizations from legal scrutiny.